← Leaderboards
Ravichandran Ramasamy
Columbia University Health Sciences
$27,700,144
Attributed
$35,343,973
Total exposure
20
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$44,095,627 · 21
By mechanism
P01$22,881,733 · 9
R01$15,971,761 · 8
R24$4,186,116 · 1
R25$468,825 · 1
T35$461,195 · 1
S10$125,997 · 1
Top collaborators
- Ann Marie Schmidt26 shared
- Shi-Fang Yan6 shared
- Gabrielle Gold-Von Simson5 shared
- Ira Jay Goldberg4 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Shi-Fang Yan$12,794,157
- Dikoma C. Shungu$12,054,848
- Evanthia Lalla$2,098,649
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsCellsDiabetes MellitusSignal TransductionHeartTissuesReperfusion TherapyMacrophagePathway InteractionsReceptor For Advanced Glycation EndproductsCardiac MyocytesLeadIn VivoLigandsMediatingInjuryPropertyCytoplasmic TailIschemiaStressInfarctionMyocardial InfarctionResponseEndothelial Cells
Grant awards (100)
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$584,113
R01 · FY2024 · DK
Core 2: Mouse, Cell and Protein Support, Data Management and Biostatistics Core$834,963
P01 · FY2023 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$615,294
R01 · FY2023 · DK
Project 1:Diabetes, RAGE/DIAPH1 and Myocardial Infarction$564,916
P01 · FY2023 · HL · contact PI
Short Term Research Training Grant for Medical Students$73,868
T35 · FY2023 · DK · contact PI
Core 2: Mouse, Cell and Protein Support, Data Management and Biostatistics Core$834,963
P01 · FY2022 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$619,879
R01 · FY2022 · DK
Project 1:Diabetes, RAGE/DIAPH1 and Myocardial Infarction$560,691
P01 · FY2022 · HL · contact PI
Short Term Research Training Grant for Medical Students$40,366
T35 · FY2022 · DK · contact PI
Core 2: Mouse, Cell and Protein Support, Data Management and Biostatistics Core$834,963
P01 · FY2021 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$636,596
R01 · FY2021 · DK
Project 1:Diabetes, RAGE/DIAPH1 and Myocardial Infarction$563,640
P01 · FY2021 · HL · contact PI
Short Term Research Training Grant for Medical Students$32,964
T35 · FY2021 · DK · contact PI
Core 2: Mouse, Cell and Protein Support, Data Management and Biostatistics Core$834,963
P01 · FY2020 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$672,000
R01 · FY2020 · DK
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$622,217
R01 · FY2020 · HL · contact PI
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2020 · HL
Project 1:Diabetes, RAGE/DIAPH1 and Myocardial Infarction$563,697
P01 · FY2020 · HL · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$519,928
R01 · FY2020 · DK
Short Term Research Training Grant for Medical Students$104,686
T35 · FY2020 · DK · contact PI
Core 2: Mouse, Cell and Protein Support, Data Management and Biostatistics Core$852,338
P01 · FY2019 · HL · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$622,217
R01 · FY2019 · HL · contact PI
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2019 · HL
Project 1:Diabetes, RAGE/DIAPH1 and Myocardial Infarction$566,237
P01 · FY2019 · HL · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$519,928
R01 · FY2019 · DK
Short Term Research Training Grant for Medical Students$143,394
T35 · FY2019 · DK · contact PI
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$849,287
R24 · FY2018 · DK
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$628,562
R01 · FY2018 · HL · contact PI
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2018 · HL
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$519,928
R01 · FY2018 · DK
Short Term Research Training Grant for Medical Students - Resubmission - 1$65,917
T35 · FY2018 · DK · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,496,524
P01 · FY2017 · HL
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$849,652
R24 · FY2017 · DK
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$636,632
R01 · FY2017 · HL · contact PI
Fatty Acids: Ischemic Protection and Repair$594,548
R01 · FY2017 · HL
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$526,420
R01 · FY2017 · DK
RAGE and Mechanisms of cardiac dysfunction$259,944
P01 · FY2017 · HL · contact PI
Biochemisty, Pathology, and Imaging Core$230,612
P01 · FY2017 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,552,037
P01 · FY2016 · HL
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$850,020
R24 · FY2016 · DK
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$530,811
R01 · FY2016 · DK
RAGE and Mechanisms of cardiac dysfunction$269,761
P01 · FY2016 · HL · contact PI
Biochemisty, Pathology, and Imaging Core$238,839
P01 · FY2016 · HL · contact PI
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular$94,426
R25 · FY2016 · DK
RAGE and Mechanisms of Vascular Dysfunction$1,528,755
P01 · FY2015 · HL
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$796,966
R24 · FY2015 · DK
RAGE and Mechanisms of cardiac dysfunction$265,550
P01 · FY2015 · HL · contact PI
Biochemisty, Pathology, and Imaging Core$235,548
P01 · FY2015 · HL · contact PI
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular$94,426
R25 · FY2015 · DK
RAGE and Mechanisms of Vascular Dysfunction$1,190,892
P01 · FY2014 · HL
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$840,191
R24 · FY2014 · DK
RAGE, Diabetes and Myocardial Infarction$399,376
R01 · FY2014 · HL · contact PI
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular$94,426
R25 · FY2014 · DK
RAGE and Mechanisms of Vascular Dysfunction$1,477,537
P01 · FY2013 · HL
RAGE, Diabetes and Myocardial Infarction$398,198
R01 · FY2013 · HL · contact PI
RAGE and Mechanisms of cardiac dysfunction$256,656
P01 · FY2013 · HL · contact PI
Biochemisty, Pathology, and Imaging Core$227,656
P01 · FY2013 · HL · contact PI
Acquisition of a Seahorse XF$125,997
S10 · FY2013 · OD · contact PI
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular$91,121
R25 · FY2013 · DK
RAGE, Diabetes and Myocardial Infarction$418,275
R01 · FY2012 · HL · contact PI
ANIMAL EXPERIMENTATION CORE$314,873
P01 · FY2012 · AG · contact PI
POLYOL PATHWAY & MECHANISMS OF ISCHEMIC INJURY IN AGING$229,258
P01 · FY2012 · AG · contact PI
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular$94,426
R25 · FY2012 · DK
RAGE and Mechanisms of Vascular Dysfunction$3,370
P01 · FY2012 · HL
RAGE and Mechanisms of Vascular Dysfunction$1,502,539
P01 · FY2011 · HL
RAGE, Diabetes and Myocardial Infarction$493,600
R01 · FY2011 · HL · contact PI
ANIMAL EXPERIMENTATION CORE$314,078
P01 · FY2011 · AG · contact PI
RAGE and Mechanisms of cardiac dysfunction$257,992
P01 · FY2011 · HL · contact PI
Biochemisty, Pathology, and Imaging Core$246,139
P01 · FY2011 · HL · contact PI
POLYOL PATHWAY & MECHANISMS OF ISCHEMIC INJURY IN AGING$230,146
P01 · FY2011 · AG · contact PI
RAGE, Diabetes and Myocardial Infarction$30,910
R01 · FY2011 · HL · contact PI
RAGE, Diabetes and Myocardial Infarction$422,500
R01 · FY2010 · HL · contact PI
ANIMAL EXPERIMENTATION CORE$302,238
P01 · FY2010 · AG · contact PI
POLYOL PATHWAY & MECHANISMS OF ISCHEMIC INJURY IN AGING$221,466
P01 · FY2010 · AG · contact PI
ANIMAL EXPERIMENTATION CORE$296,401
P01 · FY2009 · AG · contact PI
POLYOL PATHWAY & MECHANISMS OF ISCHEMIC INJURY IN AGING$217,189
P01 · FY2009 · AG · contact PI
RAGE and Mechanisms of Cardiac Dysfunction$299,564
P01 · FY2008 · HL · contact PI
ANIMAL EXPERIMENTATION CORE$287,762
P01 · FY2008 · AG · contact PI
Core--Biochemistry and Pathology Core$247,416
P01 · FY2008 · HL · contact PI
POLYOL PATHWAY & MECHANISMS OF ISCHEMIC INJURY IN AGING$210,863
P01 · FY2008 · AG · contact PI
RAGE and Mechanisms of Cardiac Dysfunction$297,950
P01 · FY2007 · HL · contact PI
Core--Biochemistry and Pathology Core$245,026
P01 · FY2007 · HL · contact PI
ALDOSE REDUCTASE AND CARDIAC ISCHEMIC INJURY$279,402
R01 · FY2006 · HL · contact PI
RAGE and Mechanisms of Cardiac Dysfunction$172,282
P01 · FY2006 · HL · contact PI
Core--Biochemistry and Pathology Core$141,960
P01 · FY2006 · HL · contact PI
ALDOSE REDUCTASE AND CARDIAC ISCHEMIC INJURY$286,125
R01 · FY2005 · HL
POLYOL PATHWAY AND ISCHEMIC INJURY IN DIABETIC HEARTS$245,250
R01 · FY2005 · HL
RAGE and Mechanisms of Cardiac Dysfunction$167,892
P01 · FY2005 · HL
Core--Biochemistry and Pathology Core$137,826
P01 · FY2005 · HL
ALDOSE REDUCTASE AND CARDIAC ISCHEMIC INJURY$286,125
R01 · FY2004 · HL
POLYOL PATHWAY AND ISCHEMIC INJURY IN DIABETIC HEARTS$245,250
R01 · FY2004 · HL
RAGE and Mechanisms of Cardiac Dysfunction$162,011
P01 · FY2004 · HL
Core--Biochemistry and Pathology Core$133,810
P01 · FY2004 · HL
ALDOSE REDUCTASE AND CARDIAC ISCHEMIC INJURY$286,125
R01 · FY2003 · HL
POLYOL PATHWAY AND ISCHEMIC INJURY IN DIABETIC HEARTS$245,250
R01 · FY2003 · HL
POLYOL PATHWAY AND ISCHEMIC INJURY IN DIABETIC HEARTS$245,250
R01 · FY2002 · HL
ALDOSE REDUCTASE AND CARDIAC ISCHEMIC INJURY$239,271
R01 · FY2002 · HL
ALDOSE REDUCTASE AND CARDIAC ISCHEMIC INJURY$232,802
R01 · FY2001 · HL
RAGE AND VASCULAR DISEASE IN DIABETES$344,816
R01 · FY2000 · HL
ALDOSE REDUCTASE AND CARDIAC ISCHEMIC INJURY$240,519
R01 · FY2000 · HL